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Abstract
Objective To systematically assess the effects of platelet-rich fibrin (PRF) on in vitro cellular behavior.
Methods A systematic electronic search using MEDLINE database was performed. In vitro studies using PRF were considered
and articles published up to June 31, 2018 were screened. Eligible studies were selected based on the use of human PRF.
Results In total, 1746 titles were identified with the search terms, from these 37met the inclusion criteria and were chosen for data
extraction. In addition, 16 new studies, mainly published in 2019, were also included in the analysis resulting in 53 studies. No
meta-analysis could be performed due to the heterogeneity of study designs. Included studies show that PRF enhances prolif-
eration, migration, adhesion, and osteogenic differentiation on a variety of cell types along with cell signaling activation.
Furthermore, PRF reduces inflammation, suppresses osteoclastogenesis, and increases the expression of various growth factors
in mesenchymal cells.
Summary and conclusions Despite some notable differences of the studies, the overall findings suggest a positive effect of PRF
on cell proliferation, migration, adhesion, differentiation, and inflammation pointing towards a therapeutic potential in regener-
ative dentistry.
Clinical relevance PRF serves as a reservoir of bioactive molecules to support wound healing and bone regeneration. Although
the cellular mechanisms by which PRF supports the clinical outcomes remain unclear, in vitro research provides possible
explanations. This systematic review aims to provide an update of the existing research on how PRF affects basic physiological
processes in vitro. The overall findings suggest that PRF induces cell proliferation, migration, adhesion, and differentiation along
with possessing anti-inflammatory properties further supporting its therapeutic potential in wound healing and bone regeneration.
Keywords Platelet-rich fibrin . In vitro . Growth factor . Cell proliferation . Cell migration . Cell differentiation .
Anti-inflammatory agents . Osteoclastogenesis
Introduction
Platelet-rich fibrin (PRF) is becoming an attractive and
widely-used approach in regenerative dentistry. PRF is a
platelet-rich plasma that undergoes natural coagulation af-
ter being separated from the red thrombus by centrifuga-
tion [1]. The evolution of PRF started with the introduction
of L-PRF based on a high-speed protocol (~ 700 g for
12 min) [1]. Later on, A-PRF (~ 200 g for 8 min) and
injectable PRF (~ 60 g for 3 min) with lower g-forces and
centrifugation times were introduced with the overall aim
to increase the number of platelets and leucocytes [2]. For
this aim, the use of centrifuges with swing-out rotors has also
been recommended [2]. Obviously PRF is an umbrella term
that comprises various preparations and protocols, therefore a
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standardization of relative centrifugal forces (RCF) [3] has
been suggested. Nonetheless, most of the clinical data derive
from the classical L-PRF protocol [1].
Recent systematic reviews dealt with the clinical applica-
tion of PRF in periodontal defects, periodontal plastic surgery
[4], sinus floor elevation, alveolar ridge preservation, or im-
plant therapy [5]. For example, PRF preserves the alveolar
ridge after tooth extraction [6], enhances osseointegration in
the early phase [7, 8] and can increase the width of keratinized
mucosa around implants [9]. Even though emerging evidence
indicates that local application of PRF can support the out-
comes of the above-mentioned clinical indications, the under-
lying cellular mechanisms remain unclear. Based on the as-
sumption that PRF supports the conserved cellular mecha-
nisms of wound healing and bone regeneration, it can, there-
fore, be assumed that PRF drives the cellular responses also
under in vitro conditions.
In vitro bioassays can confirm the impact of PRF on stan-
dard cellular responses such as proliferation, migration, and
differentiation, all of which may predict a possible clinical
efficacy. However, care should be taken when interpreting
the observations, as the early hematoma that usually forms
in defect sites is not represented in the in vitro assays [10].
Readers of this review should also be aware that some of the
observations reported for PRF have already been shown for
plasma-free leucocyte-depleted activated platelets [11–13]
based on the compelling in vitro evidence gained from
platelet-rich plasma [14, 15].
The cellular responses to PRF were summarized in a sys-
tematic review integrating seven in vitro studies [16].
However, given the increasing number of in vitro studies,
not limited to dentistry, a revised view on today's in vitro
research on PRF seems justified. This systematic review aims
to provide an update of the existing research on how PRF
affects basic physiological processes in vitro.
Material and methods
Protocol development and eligibility criteria
A protocol including all aspects of a systematic review meth-
odology was developed prior to starting the review. This in-
cluded definition of the focused question, a defined search
strategy, study inclusion criteria, determination of outcome
Fig. 1 PRISMA Flow Diagram
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measures, screening methods, data extraction, and analysis
and data synthesis.
Defining the focused question
The following focused question was defined: “what is the
effect of PRF on cell behavior in in vitro studies?”
Search strategy
An electronic search using MEDLINE database was performed.
Articles published up to June 30, 2018 were considered. No lan-
guage or time restrictions were applied in the search. However,
only studies written in English were included for selection.
Search terms
The electronic search strategy included terms related to the
intervention and used the following combination of key words
and MeSH terms: leukocyte platelet-rich fibrin” OR “pure
platelet-rich fibrin” OR “LPRF” OR “L-PRF” OR “advanced
platelet-rich fibrin” OR “APRF” OR “A-PRF” OR “L-PRF
Gel” OR “leukocytes“ OR “platelets” OR “blood platelets”
OR “platelet” AND “in vitro techniques” OR “cytokines”
OR “intercellular signaling peptides and proteins” OR “inter-
cellular”OR intercellular signaling peptides and proteins”OR
“growth factors” OR “transforming growth factor beta” OR
“bone marrow” OR “stem cells” OR “macrophages” OR “os-
teoclasts” OR “inflammation“ OR “Cell Physiological
Phenomena” OR “Cell Plasticity” OR “cell differentiation”
OR “osseointegration” OR “Dental Implants.”
Criteria for study selection and inclusion
Only in vitro studies evaluating the effect of PRF were
considered.
Exclusion criteria
In vitro studies using other kinds of platelet concentrates such
as PRGF or PRP or any other platelet concentrate that required
the addition of anticoagulant. Pre-clinical and in vitro studies
that did not use human blood.
Screening and selection of studies
Publication records and titles identified by the electronic
search were independently screened by two reviewers (JN
and ZK) based on the inclusion criteria. Discrepancies were
solved by discussion among authors (RG and FJS). Cohen’s
Kappa-coefficient was used as a measure of agreement be-
tween the readers. Thereafter, full texts of the selected ab-
stracts were obtained. The two reviewers independently
performed the screening process, i.e., from the MeSH term
search up to the full-text examination. Then, articles that met
the inclusion criteria were processed for data extraction.
Data extraction and analysis
The inclusion criteria were applied for data extraction. The
studies were classified according to study design and type of
methods applied. Then, outcomeswere compiled in tables. All
extracted data were double-checked, and any questions that
came up during the screening and the data extraction were
discussed within the authors to aim for consensus.
Results
Selection of studies
In the original search 1746 potential references were iden-
tified in Medline which 59 were eligible after title and
abstract screening (inter-reviewer agreement κ = 0.952).
Of the 59 full-text articles, 22 did not meet the inclusion
criteria and were excluded (Fig. 1) obtaining 37 studies
for data extraction (Table 1). During the submission-
process of the present review, 16 new studies meeting
the inclusion criteria were published and therefore includ-
ed for data extraction (Table 2).
Proliferation
PRF increased proliferation of mesenchymal cells, for example
from bone of different origin [19, 24–26, 28, 45, 50, 66, ], bone
marrow [32, 39], periosteum [27], adipose tissue [37, 47, 68], and
skin [65, 48]. Also, fibroblasts from gingiva [38, 44], periodontal
ligament [18, 52, 59], papilla [30], and dental pulp responded to
PRF with increased proliferation [29, 31, 43, 54]. These observa-
tions were reproduced in embryonic kidney fibroblasts and in
various cell lines such as HEK293, MG-63 osteosarcoma cells,
human oral keratinocytes, SIRC, and 3T3 cells [18].
Mesenchymal cells, endothelial cells [23, 42, 55, 63], epithelial
cells [22], and macrophages [69] also responded to PRF with
increasing proliferation. In contrast, PRF failed to induce prolif-
eration of L929 fibroblasts [53] and human mesenchymal stem
cells on collagen scaffolds [17]. In general, PRF maintained cell
viability [33, 63–66, ] without inducing apoptosis [40]. Overall,
there is a general consensus that PRF has a potent mitogenic
activity.
Migration
There are various methods to identify the impact of PRF on
cell migration including the scratch assay [70] and the tradi-
tional Boyden chamber approach [71]. Regardless of the
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Table 1 Included studies
Study (year) Cell type PRF
preparation
Method Main outcome induced by PRF
Beitzel et al. (2014)
[17]
Human mesenchymal
stem cells (MSCs)
3000 rpm
10 min
Hardware:
NR
Cell viability by live and dead staining
Cell adhesion assay to the PRF-Matrix
Cell proliferation by incorporation of
3H-thymidine
Cell viability maintained
Increased cell adhesion
No effect in cell proliferation on collagen
membranes
Burnouf et al.
(2012) [18]
Human embryonic
kidney fibroblasts
(HEK293), human
osteoblastic cell
line (MG-63),
SIRC, NIH/3T3,
periodontal
ligament
cells (PDL),
gingival fibroblasts
(GF)
700 g
12 min
Hardware:a
Cell proliferation by an automated cell
counter
Increased proliferation of all cells except
for NIH/3T3 after 7 days of stimulation
Chang et al. (2010)
[19]
Osteoblast cell line
U2OS
3000 rpm
12 min
Hardware:a
Cell proliferation by MTT assay
Western blot for ERK phosphorylation,
RANKL and OPG expression
Increased proliferation after 1, 3 and 5 days
Increased ERK phosphorylation during 5 days
and OPG expression during 3
days
Chang et al. (2011)
[20]
Periodontal ligament
fibroblasts
(PDLFs)
3000 rpm
12 min
Hardware:a
Western blot for p-ERK and OPG
ALP activity
Increased ERK phosphorylation and OPG
protein expression up to 5 days
Enhanced ALP activity up to 5 days
Clipet et al. (2012)
[21]
SaOS2 (osteoblasts),
MRC5 (fibroblasts)
KB (epithelial
cells)
400 g
12 min
Hardware: NR
Cell proliferation by SRB assay
Cytotoxic assay by SRB assay
Cell cycle analysis by flow cytometry
tests
Gene expression of cbfa1, Col1, OC
and OP by RT-PCR
Increased proliferation of SaOS2, MRC5
and KB
Enhanced G2M phase in SAOS2 and
MRC5 lineages
Up-regulation of OP and OC on SAOS2
Dereli et al. (2018)
[22]
Limbal epithelial cells PRF gel: 1000
rpm/5 min
PRF: 2700
rpm/12 min
Hardware:b
Cell viability by live and dead staining Cell viability maintained
Dohle et al. (2018)
[23]
Human outgrowth
endothelial cells
(OECs) primary
osteoblasts (pOBs)
700 rpm
3 min
Hardware:c
Co-culture of OECs with pOBs
Angiogenic activation by
immunofluorescent staining
ELISA for VEGF, PDGF-BB,
E-selectin and ICAM-1
Gene expression of VEGFA, ICAM1,
PDGF-BB, E-selectin. BMP2 and
ALP by RT-PCR
Increased VEGF concentration on pOBs
at 7 days
Increased of PDGF and E-Sel levels in
OECs and pOBs co-cultures at the
mRNA level and protein level at 24
and 72 h
Increased expression of ICAM1 and ALP
at 24 h in OECs and pOBs co-cultures
Upregulation of VEGF expression in
PRF/co-culture at 1 and 7 days
Increased BMP2 expression in PRF co-cultures
cultivated at 1 and 7 days
Ehrenfest et al.
(2009) [24]
Osteoblasts,
fibroblasts,
preadipocytes,
prekeratinocytes
400 g
12 min
Hardware:a
Proliferation assay
Cytotoxicity by MTT assay
Osteoblast differentiation by Von
Kossa and ALP staining
Increased proliferation of fibroblasts and
osteoblasts at 3, 7, 14 and 21 days in a
dose-dependent manner on osteoblasts
Absence of cytotoxicity in all cells
Increased ALP activity after 3 days and up
to 28 days and increased osteoblasts
differentiation after 7 days and up to
28 days
Ehrenfest et al.
(2010) [25]
Human bone
mesenchymal
stem cells (BMSC)
400 g
12 min
Hardware:a
Proliferation and cytotoxicity by MTT
assay
Osteoblastic differentiation by ALP
activity and quantification of the
mineralization nodules
Increased proliferation in standard and
osteogenic conditions in a dose-dependent
manner
Absence of cytotoxicity on BMSC in standard
or osteogenic conditions
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Table 1 (continued)
Study (year) Cell type PRF
preparation
Method Main outcome induced by PRF
Increased ALP activity in a dose-dependent
manner in standard and osteogenic condi-
tions
Gassling et al.
(2013) [26]
Human osteoblasts 400 g
12 min
Hardware: NR
Cell viability by live and dead staining
Biocompatibility and cell proliferation
by lactate dehydrogenase, BrdDU,
MTT and WST-1
Alkaline phosphatase activity by
ELISA
Cell viability maintained
Increased ALP activity
Gassling et al.
(2010) [27]
Human periosteal
cells
400 g
12 min
2700 rpm
Hardware:d
Cell viability by live and dead staining
Biocompatibility test by LDH test and
MTT assay
Cell Proliferation by BrdU
Cells seeded on PRF membranes maintained
their viability
PRF membranes were biocompatible
No effect on proliferation
He et al. (2009)[28] Rat calvaria
osteoblasts
400 g
10 min
Hardware: NR
Cell Proliferation
ALP activity
Mineralization assay by alizarin red
staining
Increased proliferation at 5 days and enhanced
mineralization at 14 days
No effect on ALP activity
He et al. (2016)
[29]
Human dental pulp
cell (hDPC)
400 g
10 min
Hardware: NR
Proliferation assay by CCK-8
Gene expression of ALP and DSPP by
RT-PCR
Increased proliferation after 5 and 7 days
Up-regulation of ALP and DSPP expression
Hong et al. (2018)
[30]
Human Stem Cells
of the Apical
Papilla (SCAPs)
400 g
10 min
Hardware: NR
Cell proliferation assay
Cell migration assay
Osteogenic differentiation by alizarin
red staining
Gene expression of ALP, BSP, DMP1,
and DSPP by RT-PCR
Increased proliferation at 1, 3, 5 and 7 days
Enhanced migration at 12 and 24 h
Increased mineralization at 7 and 14 days
Down-regulation of ALP, BSP, DMP1
expression but not DSPP after 7 days
Up-regulation of ALP, BSP, DMP1 and DSPP
expression after 14 days
Huang et al. (2010)
[31]
Dental pulp cells
(DPCs)
3000 rpm
10 min
Hardware:a
Cell proliferation by MTT assay
Western blot for OPG
ALP activity assay
Increased DPC proliferation at 1, 3 and 5 days
Up-regulation of OPG expression in a
time-dependent manner
Increased ALP activity
Kang et al. (2011)
[32]
Human alveolar bone
marrow stem cells
(hABMSCs)
400 g/10 min
+ 230 g
/10 min
Hardware: NR
Cell proliferation by BrdU assay
Cell migration bywound-healing assay
Mineralization by alizarin red staining
Increased proliferation
Reduced migration at 1 and 2 days
Enhanced mineralization
Khurana et al.
(2017) [33]
Dental pulp stem cells
(DPSCs) periodon-
tal
ligament stem cells
(PDLSCs)
3000 rpm
10 min
Hardware: NR
Cell viability by trypan blue Absence of cytotoxicity at 7 days
Kim et al. (2017)
[34]
Human derived
osteoblasts
400 g
10 min
Hardware:e
Cell proliferation by MTT assay
Osteoblast differentiation by
Sulforhodamine B assay
ALP activity
Increased proliferation at 1, 2 and 3 days
Enhanced osteoblast differentiation
Increased ALP activity at 2 and 3 days
Kim et al. (2017)
[34]
Human dental pulp
cells (HDPCs)
400 g
10 min
Hardware: NR
Cell viability by MTT assay
ELISA for IL-1β, IL-6, and IL-8
Western blot for VCAM1 and ICAM1
and odontoblastic differentiation
markers DSP and DMP1
ALPActivity
Mineralization by alizarin red staining
Absence of cytotoxicity
Reduced LPS-induced pro-inflammatory cyto-
kines IL-1b, IL-6, and IL-8 at 1
and 3 days
and LPS-induced adhesion molecules
VCAM1 and ICAM1 at 1 day
Enhanced LPS-induced up-regulation of
odontoblastic differentiation markers DSP
and DMP1 at 3 days
Increased ALP activity and mineralization at
day 7 in LPS treated cells
Kobayashi et al.
(2015) [35]
Human umbilical
vein endothelial
cells (HUVECs)
600 g/2 min +
500 g/4 min
+
800 g/3 min
Scratch assay
Western blot for VEGFR2
New blood vessel formation by CAM
assay
Increased migration
Enhanced phosphorylation of VEGFR2 in a
dose-dependent manner
Increased number of blood capillaries
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Table 1 (continued)
Study (year) Cell type PRF
preparation
Method Main outcome induced by PRF
Hardware:f
Fujioka-Kobayashi
et al. (2017)[36]
Human gingival
fibroblasts
L-PRF: 708
g/12 min
A-PRF: 200
g/14 min
A-PRF+: 200
g/8 min
Hardware:c
Cell viability by live-dead staining
Cell migration assay
Cell proliferation by MTS assay
Gene expression of TGFβ, PDGF, and
COL1a2 by RT-PCR
Cell viability maintained
Increased migration
Increased proliferation at 3 and 5 days
Up-regulation of PDGF and COL1a2
expression and TGFβ, PDGF and
COL1a2 at day 7
A-PRF+ produced the highest expression of
TGFβ and COL1a2
Liang et al. (2018)
[37]
Nanofat-derived
stem cells
(NFSCs)
2700 rpm
12 min
Hardware: NR
Cell proliferation by CCK-8
Gene expression of VEGF, bFGF,
PDGF and TGFβ by RT-PCR
Protein levels by Western blot
Increased proliferation
Increased expression and protein levels of
VEGF, bFGF, PDGF and TGFβ
Enhanced osteogenic, adipogenic and
chondrogenic differentiation
Miron et al. (2017)
[38]
Human gingival
fibroblasts
(HGF)
I-PRF:700 rpm
60 g
3 min
Hardware:c
Cell viability by live and dead assay
Cell migration by Boyden chamber
Cell proliferation by MTS assay
Gene expression of TGFβ, PDGF and
COL1a2 by RT-PCR
Absence of cytotoxicity
Increased cell migration
Increased proliferation after 5 days
Upregulation of COL1a2 and PDGF
expression after 3 days, and TGFβ and
COL1a2 after 7 days
Moradian et al.
(2017) [39]
Human bone marrow
mesenchymal stem
cells (BMMSCs)
400 g
10 min
Hardware: NR
Cell proliferation by MTT assay Increased proliferation at 7 days
Schär et al. (2015)
[40]
Human bone
marrow-derived
MSC and HUVEC
400 g
12 min
Hardware:b
Cell migration assay by Boyden
chambers
Increased migration ofMSC and HUVEC cells
at 7 days and at 8 h, respectively
Park et al. (2018)
[41]
Human umbilical
vein endothelial
cell (HUVEC)
400 g
12 min
Hardware:a
Cell proliferation by MTT assay
Cytotoxicity assay by adenylate kinase
(AK) release from dead cells
Cell migration by Boyden chamber
assay
Cell attachment by Green Nucleic
Stain-Kit
Increased proliferation, migration and
attachment of cells by coating
porcine-matrices with PRF
Increased cytotoxicity at day 1
Passaretti et al.
(2014) [42]
HUVEC, skin
fibroblasts
400 g
12 min
Hardware:a
Cell proliferation by Bürker chamber
counting and automated cell counter
Increased cell proliferation at 24 h
Saeed et al. (2017)
[43]
Dental pulp stem
cells (DPSCs)
2700 rpm
12 min + 1800
rpm/5 min
Hardware: NR
Cell proliferation by MTS assay
Osteogenic differentiation by alizarin
red assay
Reduced cell viability at 1 and 3 days by most
PRF concentrations
Enhanced osteogenic differentiation at 7 days
Vahabi et al. (2015)
[44]
Human gingival
fibroblasts cell
line (HGF)
400 g
12 min
Hardware: NR
Viability and proliferation by
MTT assay
Cell viability maintained during the first 24 h,
at 48 and 72 h cell viability is reduced
Increased proliferation only the first 24 h
Wang et al. (2018)
[45]
Human primary
osteoblasts
I-PRF:700 rpm
60 g
3 min
Hardware:c
Cell viability by live and dead staining
Cell migration by polyethylene
terephthalate cell culture inserts
Cell adhesion assay by staining cells
with 4′,6-diamidino-2-phenylindole
Cell proliferation by CCK-8
ALP activity assay
Mineralization by alizarin red staining
Gene expression of COL1A, Runx2,
ALP, OCN by RT-PCR
Immunofluorescence staining for OC
expression
Cell viability maintained
Increased migration at 1 day
No effect on cell adhesion
Increased proliferation at 3 and 5 days
Enhanced ALP activity andmineralized nodule
formation
Up-regulation of ALP expression at 3 days and
OCN, Runx2 and COL1A at 14 days
Increased staining intensity of OCN
Wang et al. (2017)
[46]
Human gingival
fibroblasts
700 rpm
60 g
3 min
Hardware:c
Cell viability by live-dead staining as-
say
Cell migration assay by polyethylene
terephthalate cell culture inserts
Cell adhesion assay
Cell viability maintained irrespective of the
titanium surface
Increased migration in tissue culture plates and
titanium surfaces
No effect on cell adhesion
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Table 1 (continued)
Study (year) Cell type PRF
preparation
Method Main outcome induced by PRF
Cell proliferation by CCK-8
Gene expression of PDGF, TGFβ and
COL1a1 and FN1
Collagen Type I Staining
Immunostaining
Increased cell proliferation after 3 and 5 days
Upregulation of PDGF, TGF-b, COL1 and
FN1 expression levels on all surfaces
Increased fluorescence intensity of collagen
type 1 on all surfaces.
Wei et al. (2017)
[47]
Nanofat-derived
Stem Cells
(NFSCs)
2700 rpm
12 min
Hardware: NR
Proliferation assay by CCK-8
Gene expression of adipogenic
differentiation markers PPARγ2,
C/EBPα, and ADD1 by RT-PCR
Increased proliferation after 3 days
Enhanced adipogenic differentiation
at 14 days in a dose dependent-manner
Up-regulation of PPARγ2, C/EBPα, and
ADD1 expression
Wirohadidjojo et al.
(2016)[48]
Ultraviolet-A
(UVA)-irradiated
human dermal
fibroblasts (HDFs)
400 g
12 min
Hardware: NR
Proliferation assay by MTT assay
Collagen deposition assay
Cell migration rate assay
Increased proliferation, migration and collagen
deposition in UVA-irradiated HDFs
Woo et al. (2016)
[49]
Human dental pulp
cells (HDPCs)
400 g
10 min
Hardware: NR
Cell viability by MTT and MTA assay
ALP activity assay
ALP staining
Alizarin red staining for mineralization
formation
Western Blot for DSP,DMP1, BMP
2/4, phospho-smad1/5/8
Cell viability maintained at 48 h
Increased protein levels of DSP and DMP1 and
enhanced ALP activity.
Increased mineralization
Activation of BMP 2/4 signaling and phos-
phorylation of SMAD1/5/8
Wu et al. (2012)
[50]
Human osteoblast
cell line (U2OS)
3000 rpm
12 min
Hardware:c
Cell attachment assay by WST-1 assay
Cell proliferation assay
Western blot analysis for p-Akt, HSP
47 and LOX
Increased cell attachment the first 3 h
Increased proliferation at 1, 3 and 5 days.
Enhanced Akt phosphorylation, HSP 47
expression, and LOX expression in U2OS
cells
Xu et al. (2016)
[51]
Human breast
adipose-derived
stem cells
(HBASCs)
2700 rpm
12 min
Hardware: NR
Attachment of HBASCs on scaffolds
in the presence of PRF, Rg1 or both
by fluorescence imaging
Increased proliferation and attachment on
scaffolds
Zhao et al. (2013)
[52]
Periodontal ligament
stem cells
(PDLSCs)
400 g
10 min
Hardware: NR
Cell viability and proliferation assay by
MTT assay
ALP activity
Gene expression of BSP, OCN, ColI,
and CP23 by RT-PCR
Cell viability maintained
Increased proliferation during 7 days
Reduced ALP activity at 7 days
Down-regulation of BSP and OCN expression
at 7, 14 and 21 days
Up-regulation PDL-related genes ColI and
CP23
Note. NR not reported,MTT 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide, ERK extracellular signal-regulated kinase, RANKL recep-
tor activator of NF-β ligand, OPG osteoprotegerin, ALP alkaline phosphatase, SRB sulforhodamine B, cbfa1 core-binding factor subunit alpha-1, LPS
lipopolysaccharide, VEGF vascular endothelial growth factor, ICAM-1 intercellular adhesion molecule 1, ELISA enzyme-linked immunosorbent assay,
BMP bone morphogenetic protein, RT-PCR reverse transcription polymerase chain reaction, BrdDU bromodeoxyuridine,WST-1 water soluble tetrazo-
lium-1, LDH lactate dehydrogenase,CCK-8 cell counting kit-8, BSP bone sialoprotein,DMP dentin matrix protein,MTS 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium), TGFβ transforming growth factor-β, COL1a2 collagen type I alpha 2, bFGF basic
fibroblast growth factor, Runx2 runt-related transcription factor 2, OCN osteocalcin, FN1 fibronectin, ECM extracellular matrix, PPARγ2 peroxisome
proliferator-activated receptor, C/EBPα CCAAT-enhancer-binding proteins
a PC- 02, Nice, France
bHettich EBA20, Tuttlingen, Germany
cDuo Centrifuge, Nice, France
d Eppendorf Centrifuge 5702, Hamburg, Germany
eGyrozen 406, Daejeon, Korea
fMedifuge centrifugation system, Santa Sofia, Italy
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method used, PRF increased the migration of neural stem cells
[54] along with cells of the mesenchymal lineage isolated
from bone [45, 64], bone marrow [72], gingiva [38, 64, 36],
apical papilla [30], and skin [65, 48]. Similarly, endothelial
cells responded to PRF with an increased migration [63, 72,
41]. In contrast, an inhibitory effect of PRF on cell migration
was also observed on bone marrow cells but likely due to the
aggregation and proliferation effect of PRF that precedes mi-
gration [32]. Likewise, in one recent study, PRF failed to
induce migration on L929 fibroblasts [53]. However, the gen-
eral view is that PRF supports cell motility.
Alkaline phosphatase and alizarin red staining
The main early marker of osteogenic differentiation is
alkaline phosphatase [73]. Various studies showed that
PRF increases the expression or the activity of alkaline
phosphatase in cells of the mesenchymal lineage isolated
from bone [45, ], bone marrow [25], apical papilla [30],
dental pulp [31, 34, 43, 49], periodontal ligament [59,
74], osteosarcoma cell lines [21], and other tissues [24].
Moreover, PRF increased mineralized nodules in cells
from dental pulp [34, 43, 49], calvaria bone [28], bone
marrow [32], and periodontal ligament [59]. Conversely,
one study showed an inhibitory effect of PRF on alkaline
phosphatase activity [52]. In two other reports, PRF
failed to change alkaline phosphatase activity and did
not change alkaline phosphatase expression in rat
calvaria osteoblasts [28] and bone marrow cells [40],
respectively. Taken together, all but three studies report-
ed an increase of alkaline phosphatase in response to
PRF exposure.
Growth factors and extracellular matrix
PRF caused a moderate expression of various growth factors
in mesenchymal and endothelial cells such as TGFβ [38, 46,
52, 56, 65, 36], PDGF [23, 38, 40, 46, 52, 56, 65, 36], and
VEGF [23, 37, 58]. Dental pulp cells treated with PRF in-
creased expression of dentin sialoprotein and dentin matrix
protein 1 [29, 34, 49]. With respect to changes in the expres-
sion of extracellular matrix protein, PRF increased collagen
type 1 in mesenchymal cells of the bone [45], skin [65], and
gingiva [38, 73]. Likewise, PRF increased the expression of
osteopontin, MMP2, and MMP9 in human bone marrow cells
[40]. Conversely, PRF reduced the expression of bone
sialoprotein and osteocalcin along with a transient downregu-
lation of collagen type 1 in periodontal ligament cells [52].
Similarly, a downregulation of bone sialoprotein, dentin ma-
trix protein 1, and dentin sialoprotein in cells from the papilla
was reported [30]. It should be noted, however, that this down-
regulation disappeared after 14 days of stimulation [30]. In
general, the reported increase of gene expression by PRF is
moderate.
Cell adhesion
Cell adhesion proteins were enhanced by PRF, for exam-
ple, ICAM-1 and E-selectin in cocultures of osteogenic
and endothelial cells [23] and ICAM-1 in pulp cells
[34]. Furthermore, PRF supported adhesion of mesenchy-
mal cells [17], HUVEC [41], U2OS [50], and HBASC
[51] on different scaffolds. These positive results nonethe-
less were not replicated on titanium surfaces [46] and
culture plates [45]. Together, these observations suggest
that in the majority of experiments, PRF could support
cell adhesion.
Cell signaling, inflammation, and osteoclastogenesis
PRF enhanced the phosphorylation of Akt, heat shock
protein 47 and lysis oxidase in osteosarcoma cells [50],
and VEGFR2 in endothelial cells [35]. PRF enhanced
phosphorylation of ERK in osteosarcoma cells [19],
and periodontal fibroblasts [74] along with an increase
in OPG expression in both cell types. This PRF-induced
OPG expression was also reported on dental pulp cells
[31]. Moreover, PRF reduced LPS-induced cytokine pro-
duction in pulp cells and enhanced the up-regulation of
odontoblastic differentiation markers DSP and DMP-1 in
these cells [34]. Similarly, PRF suppressed the LPS- and
saliva-induced pro-inflammatory cytokines on primary
and RAW264.7 macrophages and attenuated the translo-
cation of NF-κB into the nucleus [69]. This anti-
inflammatory effect was replicated in gingival fibroblasts
[61]. In addition, in dental pulp cells, PRF increased DSP
and DMP1 expression along with an activation of BMP 2/
4 signaling and phosphorylation of SMAD1/5/8 cascade
[49]. Osteoclasts originate from hematopoietic progenitors
and in the presence of the survival factor (M-CSF) and
RANKL differentiate into osteoclasts staining positive for
TRAP. PRF suppressed the expression of osteoclast mark-
er genes TRAP, DCSTAMP, NFATc, and OSCAR.
Altogether, these results suggest that PRF can affect cen-
tral signaling pathways, possesses an anti-inflammatory
effect, and is capable of inhibiting osteoclastogenesis
[57].
Discussion
This systematic review encompassed in vitro studies using
PRF and can be viewed as an extension of the previous
work of Miron et al. [16]. Our aim was to gather the
current in vitro evidence on cellular responses to PRF.
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Table 2 Included studies
Study (year) Cell type PRF
preparation
Method Main outcome induced by PRF
Bucur et al.
(2019) [53]
Fibroblast cell line L929 200 g
14 min
Hardware:
NR
Cell proliferation and migration using RCTA
Scratch assay
No effect on proliferation neither on
migration
Elgamal et al.
(2019) [47].
Adipose mesenchymal
stem cells (MSC)
1500 rpm
14 min
Hardware:
NR
Cell proliferation by MTT assay Increased proliferation
Gervois et al.
(2019) [54]
Human dental pulp stem
cells (hDPSCs),
neural stem cell
(NSC)
400 g
12 min
Hardware:c
Metabolic activity assay by MTT assay
Cell proliferation by PI assay
Cell migration by transwell migration assay
Decreased and increased metabolic
activity, dependent on the PRF
concentration
Increased proliferation of hDPSCs but
no effect on NSC
Increased migration of NSC
Gomez et al.
(2019) [55]
Endothelial cells (EC) 2000 rpm
7 min
Hardware:
NR
Counting of the cells viewed under phase-contrast micro-
scope
Increased cell growth
Herrera-Vizcaíno
et al. (2019)
[56]
Human dermal vascular
endothelial cells
(HDMECs)
Human fibroblasts (HF)
44 g or
710 g
8 min
Hardware:a
Immunostaining of endothelial cells marker CD31
Immunohistochemical detection of CD31
Protein levels of VEGF, PDGF-BB and TGFβ by ELISA
Increased CD31-positive cells
Increased concentration of PDGF-BB
of TGFβ at day 4 in HDMECs and
HF
No effect on VEGF
Kargarpour et al.
(2019) [57]
Murine primary
macrophages,
RAW264.7 cells
1570 rpm
12 min
Hardware:d
Cell viability by MTT assay and live-dead staining
Cell proliferation by BrdU
Caspase 3 activity assay
Western blot for cleaved caspase 3
Gene expression of osteoclast marker genes TRAP,
Cathepsin K, DCSTAMP, NFATc1, OSCAR and pro and
anti-apoptotic marker genes, caspase-3, Bax and
Bcl2L1 by RT-PCR
TRAP staining
Pit formation assay
Maintenance of cell viability and
enhanced cell proliferation
Reduced caspase 3 activity and
suppression of cleaved caspase-3
Supression of osteoclastogenesis
Suppression of the expression of
TRAP, Cathepsin K, DCSTAMP,
NFATc1, OSCAR
Reduced number of multinucleated
TRAP positive cells
Reduced pit formation on dentine
slices
Kasnak et al.
(2019) [58]
Human oral
keratinocyte (HMK)
cells
2700 rpm
15 min
Hardware:e
Cell proliferation by CellTiter 96 assay
Protein levels of IL1β, IL1Ra, IL8, MCP1, and VEGF by
ELISA
Increased proliferation on titanium and
hydroxyapatite discs
Increased concentration of IL1β,
IL1Ra, IL8, MCP1, and VEGF on
titanium and hydroxyapatite discs
Li et al. (2018)
[59]
Human periodontal
ligament cells
(hPDLCs)
750 g
12 min +
500 g
5 min
Hardware:
NR
Cell proliferation using CCK-8
ALP activity assay
Mineralization assay by alizarin red staining
Gene expression of RUNX2, Osterix and Osteocalcin by
RT-PCR
Protein expression of RUNX2 by Western blot
Increased proliferation at day 1, 2 and
3
Increased ALP activity at 7 and
14 days
Increased mineralization at 14 days
Increased expression of RUNX2,
Osterix at 5 and 7 days and
Osteocalcin at 7 days
Increased protein expression of
RUNX2 at day 5
Mahendran et al.
(2019)[60]
Fibroblast cell line L929 3000 rpm
10 min
Hardware:
NR
Cell viability by MTT assay Maintenance of cell viability
Mudalal et al.
(2019) [61]
Human gingival
fibroblast
3000 rpm
12 min
Hardware:b
Gene expression of IL1β, IL6 and TNFα by RT-PCR Decreased expression of IL1β, IL6 and
TNFα
Nasirzade et al.
(2019) [62]
Murine primary
macrophages,
Raw 264.7 cells
1570 rpm
12 min
Hardware:d
Gene expression of M1 marker genes IL1β, IL6; M2 genes
Arg1, Ym1 and lipoxygenases, ALOX12, and ALOX15
by RT-PCR
IL6 levels by ELISA
NF- B intracellular translocation by Immunofluorescent
Decreased expression of IL1β and IL6
Increased expression of Arg1, Ym1
and lipoxygenases
Increased IL6 protein level
Reduced intracellular translocation of
NF- B
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Despite the steadily increasing number of in vitro studies,
much of the available evidence has focused on confirming
similar findings. The majority of studies assessed the
impact of PRF on proliferation, adhesion, migration,
and differentiation mainly on mesenchymal cells and
to some extent, endothelial and epithelial cells.
Overall, PRF triggered an increase in the above-
mentioned parameters and revealed anti-inflammatory
properties. PRF also showed a moderate but consistent
capacity to modulate the expression of target genes ac-
tivating different signaling pathways.
A meta-analysis could not be performed as the included
studies revealed heterogeneity in terms of study design,
evaluation methods, outcome measures, and observation pe-
riods. Besides the original L-PRF protocol, other PRF proto-
cols were used, however, most studies did not provide enough
details. These details are of importance as with different pro-
tocols [3], i.e., centrifugation time and g-force, characteristics
such as the release of growth factors or the content of living
cells are substantially changed [75]. For instance, by reducing
the g-force, there is an improvement in growth release and cell
content. This finding is considered one of the major innova-
tions in PRF leading to the development of new protocols
including advanced platelet-rich fibrin (A-PRF+), injectable
PRF (i-PRF), and liquid PRF (fluid-PRF). In addition, there
are other factors that were not considered in the different
Table 2 (continued)
Study (year) Cell type PRF
preparation
Method Main outcome induced by PRF
Ratajczak et al.
(2018) [63]
HUVEC 400 g
12 min
Hardware:c
Cell proliferation byMTTassay and propidium iodide assay
Cell migration by transwell migration assay
Angiogenic potential by Tube Formation assay
Increased proliferation
Enhanced migration
Increased tube formation
Steller et al.
(2019) [64]
Primary human
osteoblasts (OB)
400 g
10 min
Hardware:f
Viability by MTT assay
Cell adhesion to titanium surface by RTCA and cell wash
assay
Maintenance of cell viability
No effect on adhesion to titanium
surface
Steller et al.
(2019) [64]
Human gingival
fibroblasts (GF),
human osteoblasts
(hOB)
400 g
10 min
Hardware:f
Cell viability by MTT assay
Cell migration by scratch assay
Cell viability maintained at 24 and
72 h in OB and at 72 h in GF
Increased migration of GF and OB at
24, 48 and 72 h
Increased proliferation
Verboket et al.
(2019)[40]
Bone marrow
monuclear cells
(BMC)
60 g
3 min
208 g
8 min
Hardware:a
Metabolic activity by MTS assay
Gene expression of VEGFA, ICAM1, MMP2, MMP7,
MMP9, TGF-β1, BCL2, BAX, ALP, COL1a1, FGF23,
and OPN by RT-PCR
Determination of apoptosis using Annexin-V-staining
Increased metabolic activity at day 14
Increased expression of SPPI at day 2
and 7, TGFβ, MMP2, at day 7 and
MMP9 at day 14
No effect on ICAM, ALP, COL1a1,
FGF23 and other genes.
PRF did not induce apoptosis
Wang et al.
(2019) [65]
Dermal skin
fibroblast cell
60 g
3 min
Hardware:
NR
Cell viability using live and dead staining
Cell migration assay
Cell proliferation using CCK-8
Gene expression of PDGF, TGFβ, COL1a1, and
FN1 by RT-PCR
Immunofluorescent staining of collagen type I
Maintenance of cell viability
Increased the migration
Increased proliferation at day 3 and 5
Increased expression of PDGF, TGFβ,
COL1a1, and FN1 at 3 and 7 days.
Increased collagen type I staining
Note. NR not reported, MTT 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide, ALP alkaline phosphatase, COL1A1 collagen 1 alpha 1,
RT-PCR reverse transcription polymerase chain reaction,ELISA enzyme-linked immunosorbent assay, VEGF vascular endothelial growth factor, ICAM1
intercellular adhesion molecule, SPPI osteopontin, PDGF-BB platelet-derived growth factor, PI propodeum iodide, BDNF brain-derived neurotrophic
factor, CCK-8 cell counting kit-8, TGFβ transforming growth factor-β, TRAP tartrate-resistant acid phosphatase, DCSTAMP dendritic cell-specific
transmembrane protein, NFATc1 nuclear factor of activated T-cells, OSCAR osteoclast-associated receptor, Bax Bcl2-associated x protein, Bcl2 B cell
lymphoma 2, MCP-1 monocyte chemotactic protein-1, MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium), FGF23 basic fibroblast growth factor, TNF-α tumor necrosis factor, Arg1 arginase-1, ALOX arachidonate lypoxigenase, NF nuclear factor kappa-
light-chain-enhancer of activated B cells, RTCA real-time-cell analyzer assay, M-CSF macrophage colony stimulating factor, MMP matrix metallopro-
teinase, FN1 fibronectin
a Duo Centrifuge, Nice, France
b Eppendorf Centrifuge 5702, Hamburg, Germany
c Intraspin TM, Intra-Lock International, Boca Raton, FL
d Z 306 Hermle Universal Centrifuge, Wehingen, Germany
e SL8R, Thermo Fisher Scientific, Waltham, MA
fAllegra X-12R-Centrifuge, Brea, California
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preparation protocols such as the centrifugation tubes which
have a strong impact on the clot size [76]. Indeed, the silica
used to coat plastic tubes might contaminate PRF and
thereby provoking inflammation [77]. Likewise, differences
in g-forces, blood volume, hematocrit levels, centrifugation
time, and handling of PRF membranes impede an accurate
comparison between the protocols. Furthermore, PRF lysates,
PRF conditioned medium, and PRF exudates should also be
distinguished from traditional protocols. Although these is-
sues are at the heart of scientific discussion [78, 79], the main
in vitro findings are rather consistent.
Successful tissue regeneration and osseointegration rely on
the response of the surrounding cells. These biological pro-
cesses inevitably require proliferation, migration, and differ-
entiation of cells at the treatment site.
PRF consistently increased cell proliferation irrespective of
the cell type and PRF preparation. One interesting setting was
the increased cell proliferation on collagen matrices [72] and
titanium surfaces [46] upon PRF coating. It is worth noting
that two studies found a conspicuously reduced proliferation
in gingival fibroblast [44] and dental pulp stem cells [43]. It is
difficult, however, to determine why PRF led to a decline in
cell proliferation. PRF membranes covering cells might de-
crease oxygenation [44]. Nonetheless, PRF preparation with-
out providing enough details complicates the interpretation of
the data [43]. Despite these shortcomings, the majority of the
in vitro studies suggest a mitogenic activity of PRF for various
cell types that might be attributed to the strong mitogen PDGF
released by activated platelets [13, 80].
Cell migration was positively induced in all but two of the
selected studies. This chemotactic effect is likely due to the
presence of growth factors contained in platelets such as
PDGF [12]. This growth factor, for example, pushes prolifer-
ation of osteogenic cells in vitro [81]. In addition, endothelial
cells followed a similar pattern of displaying an increase in
migration upon exposure to PRF [40]. Although the activation
of platelets might account for these observations [11], the
precise mechanism remains to be elucidated. In support of
the mitogenic and chemotactic activity, PRF enhanced the
phosphorylation of Akt [50], and ERK [19, 74] similar to what
is observed in isolated platelets [12]. Conversely, inhibition of
migration by PRF has been reported in alveolar bone marrow
cells [32]. This effect might be explained by the aggregation
and proliferation effect of PRF that precedes migration and
also by methodological differences, which precludes an inter-
pretation and a comparison with the other studies [3]. Despite
these inconsistencies, PRF is able to induce cell migration,
likely due to the presence of growth factors such as PDGF
with chemotactic activity.
Cell differentiation is commonly assessed by means of
measuring alkaline phosphatase and alizarin red staining.
Various studies showed that PRF increases the expression or
the activity of alkaline phosphatase in cells of the
mesenchymal lineage [24, 25, 29–31, 34, 43, 45, 49, 65, 59,
74]. Some data, nonetheless, are conflicting since PRF can
also reduce alkaline phosphatase activity [52] consistent with
the effects of supernatants of isolated platelets [12]. This re-
duction may be attributed to TGF-β [82] and PDGF [12]. On
the other hand, the increased mineralized nodules elicited by
PRF in cells from dental pulp [34, 43, 49], calvaria bone [28],
bone marrow [32], and periodontal ligament [59] appear to be
a consequence of the enhanced proliferation, alkaline phos-
phatase activity, and production of collagen matrix. These
in vitro findings, however, have to be interpreted with caution
as proliferation and differentiation do not occur simultaneous-
ly [73].
With respect to growth factors such as TGFβ, PDGF, and
VEGF, PRFmoderately increased their expression. Regarding
extracellular matrix proteins, PRF moderately increased the
expression of collagen type 1, which is a known TGFβ target
gene [83, 84] in mesenchymal cells of various origins. In line
with collagen type 1 synthesis, PRF activates the expression
of HSP47 and lysine oxidase [50]. Cell adhesion proteins were
enhanced by PRF [23], however, they are not necessarily re-
sponsible for the increased cell adhesion on different scaffolds
[51]. Together, these observations suggest that PRF induces
moderate changes in gene expression. In contrast, recent data
at our lab indicate a robust activation of TGFβ target genes
IL11, PRG4, and NOX4 by PRF lysates (Di Summa et al.
unpublished observation). TGF-β couples osteogenesis with
angiogenesis by providing a pro-osteogenic microenviron-
ment in vivo [62]. As TGF-β induces pro-osteogenic factors
and TGF-β type 1 receptor inhibitor rescues uncoupled bone
remodeling in vivo [62], PRF-derived TGF-β may support
bone regeneration.
This systematic review revealed an anti-inflammatory ef-
fect of PRF. Moreover, during the submission process of the
present review, new studies were published highlighting these
anti-inflammatory effects of PRF. For example, PRF reduced
the LPS-induced proinflammatory cytokine release in gingival
fibroblasts [61]. In addition, we have recently shown that PRF
reduces the expression of the M1 marker genes interleukin 1β
(IL1β) and interleukin 6 (IL6) in bone marrow macrophages
[69]. This anti-inflammatory effect might be explained by the
high amounts of TGFβ in PRF [73] capable of modulating the
M1 and M2 polarization along with the generation of pro-
resolving lipid mediators [69]. Additionally, PRF induces
the expression of the M2 markers arginase-1 and chitinase-
like 3 (Chil3 or YM1) thereby assisting a M1-to-M2 transition
[69]. Since dental implants activate the immune system during
the early stages of osseointegration [85], the addition of PRF
may support a M2 polarization reducing the time lag for
osseointegration and bone regeneration. Notably, PRF can
also decrease the formation of osteoclast-like cell in a murine
bone marrow culture [57]. Similar findings were also reported
in peripheral blood mononuclear cells derived CD14+ cells
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[86]. These observations are of particular interest since the
favorable effects of PRF in alveolar ridge preservation [6]
might be partly explained by an inhibition of osteoclastogen-
esis. Thus, accumulating evidence suggest that PRF possesses
an anti-inflammatory activity and is capable of suppressing
osteoclastogenesis.
PRF is a potent inducer of the in vitro angiogenic process
indicated by endothelial proliferation, migration, and tube for-
mation. PRF supports microvessel-like structures [23, 56] and
induces blood vessel formation in the chorioallantoic mem-
brane assay [63]. Apart from in vitro angiogenesis, a recent
report described an antimicrobial effect of PRF. In that study,
both PRF membranes and PRF exudates had an antimicrobial
effect against P. gingivalis, a key periodontal pathogen [87].
Those findings support the rationale of using PRF as an adjunc-
tive therapy for peri-implantitis [88]. These observations are
also in line with previous data on purified activated platelet
showing an angiogenic [11] and antimicrobial effect [89].
Overall, these findings imply that PRF possesses angiogenic
and antimicrobial properties.
We recognize that the present report has a number of
limitations. PRF is widely used in regenerative dentistry,
however, in vitro models represent only a narrow aspect
of wound healing and bone regeneration neglecting the
holistic nature of an in vivo model. Furthermore, and con-
sidering that wound healing and bone regeneration in-
volve granulocytes, lymphocytes and other cell types, to-
day’s PRF research only covers a restricted spectrum of
cells. It should also be noted that the same stimuli may
play different roles depending on the differentiation stage
of the target cell. For example, our group demonstrated
that PRF membranes inhibit the formation of osteoclasts
in bone marrow cultures [57]. This inhibition, however,
did not occur when osteoclastogenesis had already started
[57].
Future studies should, for example, include research on the
immigration and activation of granulocytes and how PRF
might control the resolution of inflammation. Moreover, and
considering the importance of centrifugation tubes and the
possible impact of silica coating, more studies investigating
this issue are needed for the optimization of PRF. Finally, the
overall question of whether the in vitro PRF research reflects
the clinical reality serving as a surrogate parameter to adapt
the current PRF protocols remains to be clarified.
Conclusion
Despite some notable differences of the included studies, the
overall findings suggest a benefit of PRF on cell proliferation,
migration, adhesion, differentiation, and inflammation
pointing towards a therapeutic potential in wound healing
and regeneration.
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